Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1802778
Max Phase: Preclinical
Molecular Formula: C19H15FN4
Molecular Weight: 318.36
Molecule Type: Small molecule
Associated Items:
ID: ALA1802778
Max Phase: Preclinical
Molecular Formula: C19H15FN4
Molecular Weight: 318.36
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cc1[nH]c2ccccc2c1-c1ccnc(Nc2ccc(F)cc2)n1
Standard InChI: InChI=1S/C19H15FN4/c1-12-18(15-4-2-3-5-16(15)22-12)17-10-11-21-19(24-17)23-14-8-6-13(20)7-9-14/h2-11,22H,1H3,(H,21,23,24)
Standard InChI Key: MHFAEQWEFZACHX-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 318.36 | Molecular Weight (Monoisotopic): 318.1281 | AlogP: 4.82 | #Rotatable Bonds: 3 |
Polar Surface Area: 53.60 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 13.35 | CX Basic pKa: 1.88 | CX LogP: 4.64 | CX LogD: 4.64 |
Aromatic Rings: 4 | Heavy Atoms: 24 | QED Weighted: 0.57 | Np Likeness Score: -1.37 |
1. Bryk R, Wu K, Raimundo BC, Boardman PE, Chao P, Conn GL, Anderson E, Cole JL, Duffy NP, Nathan C, Griffin JH.. (2011) Identification of new inhibitors of protein kinase R guided by statistical modeling., 21 (13): [PMID:21632247] [10.1016/j.bmcl.2011.04.149] |
Source(1):